Laboratorio Farmaceutico Erfo Logo

Laboratorio Farmaceutico Erfo

Full-service contract manufacturer of private label supplements and medical devices.

ERFO | XMIL

Overview

Corporate Details

ISIN(s):
IT0005497836 (+1 more)
LEI:
8945005CB564D0OBQQ85
Country:
Italy
Address:
VIALE GEKI RUSSO, SNC (PONTE GALLO), 98049 VILLAFRANCA TIRRENA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Farmaceutico Erfo S.p.A. is an innovative company specializing in the nutraceutical sector. The firm provides contract manufacturing services for food supplements and medical devices, offering a comprehensive, end-to-end solution for third-party brands. Its services span the entire product development lifecycle, from formulation and raw material selection to production, packaging design, and legal consulting. Operating from a modern, ISO 9001:2015 certified facility authorized by the Italian Ministry of Health, Erfo supports clients with both small-batch and large-scale production runs for private label products. The company manufactures various pharmaceutical forms, including capsules, tablets, sachets, vials, and bottles. Erfo is a registered Benefit Corporation (Società Benefit).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 07:27
Regulatory Filings
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IIIQ 2025
Italian 696.9 KB
2025-11-11 08:24
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione regolamento attuativo piano…
Italian 410.6 KB
2025-10-17 08:00
Regulatory Filings
ERFO parteciperà alla sesta edizione della conferenza "NEXT GEMS"
Italian 453.6 KB
2025-10-15 19:00
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Assemblea approva piano di incentivazion…
Italian 403.6 KB
2025-09-30 17:09
Pre-Annual General Meeting Information
Laboratorio Farmaceutico Erfo S.p.A. - Pubblicazione Avviso di Convocazione e d…
Italian 450.0 KB
2025-09-27 16:21
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione relazione semestrale consol…
Italian 1.5 MB
2025-08-28 18:09
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A.: 1H 2025 financial figures
English 502.5 KB
2025-08-28 13:00
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IH 2025
Italian 334.1 KB
2025-08-20 23:05
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-08-09 11:14
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.2 KB
2025-08-02 09:19
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.9 KB
2025-07-25 20:05
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 374.5 KB
2025-07-18 20:04
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.1 KB
2025-07-12 09:39
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-07-04 18:21
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.3 KB

Automate Your Workflow. Get a real-time feed of all Laboratorio Farmaceutico Erfo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Farmaceutico Erfo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Farmaceutico Erfo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.